Market Participants Take Note of Regeneron Pharmaceuticals Options
Investors are closely watching the recent moves concerning Regeneron Pharmaceuticals (NASDAQ: REGN) as wealthy market players display a noticeable bearish sentiment. This shift in options trading patterns is something that market participants need to take seriously. These major trades signal anticipation for impactful changes ahead regarding REGN.
Recent observations from options activity reveal a significant uptick in transactions, with 8 unusual options activities identified. Such a level of trading volume typically precedes noteworthy events in the company.
Assessing the Current Rate of Price Movement
Recent analyses show that key market influencers are concentrating on guiding REGN's price within a range of $530.0 to $1095.0 during the last few months. This range signifies levels that traders are particularly focused on.
Volume and Open Interest Insight
Today's options trading indicates a mean open interest of 92.17 for REGN. The total volume of options associated with Regeneron stands at 41.00, a clear indication of active market interest.
Important Options Trading Details
Monitoring recent trades over the past month, it becomes apparent where significant trades have landed. The trading behavior for options on REGN illustrates how traders are navigating their positions within the market.
Noteworthy Options Trades
During our tracking, we've detected several key trades that highlight market trends:
- Symbol: REGN
Type: PUT
Trade Type: TRADE
Sentiment: BEARISH
Expiration Date: 12/18/26
Price: $122.0
Strike Price: $950.00
Total Trade Price: $61.0K
Open Interest: 55
Volume: 10 - Symbol: REGN
Type: PUT
Trade Type: TRADE
Sentiment: BEARISH
Expiration Date: 12/18/26
Price: $122.0
Strike Price: $950.00
Total Trade Price: $61.0K
Open Interest: 55
Volume: 5 - Symbol: REGN
Type: CALL
Trade Type: TRADE
Sentiment: NEUTRAL
Expiration Date: 05/16/25
Price: $35.4
Strike Price: $1095.00
Total Trade Price: $49.5K
Open Interest: 15
Volume: 14 - Symbol: REGN
Type: CALL
Trade Type: TRADE
Sentiment: BULLISH
Expiration Date: 12/18/26
Price: $483.1
Strike Price: $530.00
Total Trade Price: $48.3K
Open Interest: 3
Volume: 0 - Symbol: REGN
Type: CALL
Trade Type: TRADE
Sentiment: NEUTRAL
Expiration Date: 02/21/25
Price: $91.9
Strike Price: $920.00
Total Trade Price: $45.9K
Open Interest: 17
Volume: 5
About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is dedicated to discovering and producing innovative products aimed at treating conditions such as eye diseases, cardiovascular issues, cancers, and inflammatory disorders. Among their well-known products are Eylea for age-related macular degeneration, Praluent for lowering LDL cholesterol, Dupixent for various immunology conditions, Libtayo for cancer treatment, and Kevzara for rheumatoid arthritis. Furthermore, Regeneron actively engages in developing advanced therapies in collaboration with other entities, focusing on cutting-edge technologies including CRISPR gene editing.
Current Status of Regeneron Pharmaceuticals
- Trading volume stands at 96,123, with REGN showing a decline of -2.34% and settling at $939.78.
- Relative Strength Index (RSI) indicates the stock might be undersold at present.
- The upcoming earnings report is anticipated shortly.
Analyst Insights on Regeneron Pharmaceuticals
In the past month, a cohort of five industry analysts shared their evaluations regarding REGN, predicting an average target price around $1155.2.
While options trading carries its set of risks, it can also yield higher rewards. Experienced options traders utilize various strategies including education, diligent monitoring of market trends, and smart entry and exit tactics to mitigate risks associated with their trades.
To keep abreast of the latest options activity for Regeneron Pharmaceuticals, real-time alerts and updates are available through services that cater specifically to options traders.
Frequently Asked Questions
What is the current sentiment among Regeneron investors?
The sentiment appears bearish, with a significant portion of options trades indicating potential downward trends.
What is the recent price range for Regeneron’s stocks?
The stock's price is currently trading between $530.0 and $1095.0, showcasing volatility in recent months.
How many options have been traded for Regeneron recently?
Recent activity indicates 8 notable options movements, signaling heightened trading interest.
What are Regeneron's primary products?
Key products include Eylea, Praluent, Dupixent, Libtayo, and Kevzara, addressing various medical conditions.
What do analysts predict for Regeneron's stock?
Analyst averages suggest a target price of approximately $1155.2, reflecting a mix of optimism and caution based on market conditions.
